Specific types of biological tissue have specific functions that are enabled by their structures. Tissue functions can include transport of nutrients into a tissue or byproducts out of a tissue, metabolic function, load bearing, actuation, transmission of nervous system stimuli, and more. Tissue structure includes the types of cells and other materials that are included in the tissue, as well as the organization of these elements with respect to each other. Some of a tissue's structural features are at small length scales, such as the scale of individual cells and extracellular matrix. Other features are at larger length scales, such as vasculature and the quasi-layered organization of cells in skin, bone, and cartilage. In general, tissues function properly because the proper elements (e.g., cells and extracellular matrix (ECM)) interact with each other in the ways that the tissues, organs, and the organism require.
An illustrative example of biological tissue having a function that is enabled by its structure is liver tissue. Liver tissue comprises repeating functional subunits called liver lobules. Each liver lobule carries out the array of typical liver functions, including synthesizing proteins such as albumin for sustaining osmotic pressure in the circulatory system, metabolizing drugs and other chemicals, filtering the blood, and secreting bile. In part, these functions are made possible by the types of cells that are included in the liver lobules, with hepatocytes synthesizing proteins and metabolizing drugs, and with endothelial cells forming the vasculature (called sinusoids) through which the blood flows in order to be filtered in the liver. The functions are also made possible by the orientation and arrangement of the cells with respect to each other. For example, blood flows through the narrow liver sinusoids, which are primarily walled with endothelial cells. The endothelial cells are fenestrated (i.e., they contain pores). The fenestrations are too small to permit pressure-driven flow from the interior of the sinusoids into the sheets of hepatocytes that lie outside the sinusoids. The ECM that primarily occupies the space between the endothelial cells and the hepatocytes (the Space of Disse) also prevents direct flow from the interior of the sinusoids to the hepatocytes outside of the sinusoids. However, transport of species between the blood flow (inside the sinusoids) and the hepatocytes (outside the sinusoids) does take place. This transport takes place by diffusion across the fenestrated endothelium and across the Space of Disse; nutrients diffuse to the hepatocytes, and the hepatocytes' products diffuse back to the sinusoids.
In certain embodiments, the invention relates to a device comprising a first sheet and a second sheet folded in an interlocking pattern, thereby forming a stack of co-folded layers; wherein
In certain embodiments, the invention relates to a method of making a device comprising a first sheet and a second sheet, comprising the step of:
In certain embodiments, the invention relates to a method of using any of the devices described herein, comprising the step of introducing into the first flow path a fluid.
In certain embodiments, the invention relates to a multi-material, multi-functional microfluidic device comprising a folded architecture that mimics the layered arrangement of cells in certain tissues. In certain embodiments, the device is suitable for tissue engineering (for example, for drug screening or implants), biological sensing, or diagnostics. In certain embodiments, the invention relates to a method of making any of the devices described herein without the use of alignment tooling. Because a single process integrates multiple materials, process compatibility is not a constraint.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device comprises at least two planar sheets, wherein the first sheet and the second sheet are folded in an interlocking pattern, thereby forming a stack of co-folded layers. In certain embodiments, the first sheet and the second sheet comprise different materials. In certain embodiments, the first sheet and the second sheet comprise the same materials. In certain embodiments, the devices enable different biological functions (e.g. flow and diffusion) because of their interlocked folded architecture. In part, “interlocked” means that the sheets are co-folded in a regularly or irregularly alternating pattern. “Interlocked” also means that the sheets are folded from different directions. For example, the two sheets may be patterned into strips that are oriented 90 degrees apart and are folded alternately with each other to produce a multi-material stack.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device has multiple functions because the co-folded sheets have different structures or compositions.
In certain embodiments, the invention relates to any of the devices described herein, wherein the folded architecture results in alignment of structures or features in the first sheet or the second sheet. In certain embodiments, a layer can constrain folding of subsequent layers. As used herein, the term “align” is intended to include “substantially align.” In other words, if a portion of the structure or feature aligns or overlaps with a portion of another structure or feature, such that the function of those structures or features is relatively unaltered (e.g., flow still occurs), the structures or features are aligned. However, when structures or features “do not align” with each other, there is 0% overlap of these structures or features in the device.
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet or the second sheet, or both, is cut; patterned; imbued with absorbed materials, coatings, or other functional inclusions; or have inherent material or structural properties that make it so that each layer in the co-folded stack imparts its own function or functions to the full stack. In certain embodiments, the first sheet or the second sheet comprises a pre-patterned “origami crease” in order to ensure proper folding and alignment without the use of an alignment tool.
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet or the second sheet, or both, comprises an adhesive. In certain embodiments, the adhesive adheres the first sheet and the second sheet, ensuring that the co-folded layers remain in place after the folding is complete and preventing leakage.
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet or the second sheet, or both, is biodegradable, for example, for implantable tissues.
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet or the second sheet, or both, is not biodegradable (i.e., is stable), for example, for external use (e.g. drug screening).
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet comprises polyimide or polydimethylsiloxane (PDMS). In certain embodiments, the first sheet is substantially impermeable to water.
In certain embodiments, the invention relates to any of the devices described herein, wherein the second sheet is nanoporous. In certain embodiments, the invention relates to any of the devices described herein, wherein the second sheet is a nanoporous membrane. Inclusion of a co-folded nanoporous membrane creates interfaces through which diffusion will occur but flow will not. The surface area of the membrane exposed to the central holes can vary, e.g., depending on the physiological ratio of the surface area to the volume of the tissue to be modeled, volume of the microchannels, cell analysis and/or detection methods, and any combinations thereof. A proper ratio of the surface area of the membrane exposed to the central holes to the volume of the central holes can ensure that the device can function more like an in vivo tissue, which can in turn allow for in vitro results to be extrapolated to an in vivo system. In accordance with some embodiments of the invention, the surface area of the membrane exposed to the central holes can be configured to satisfy the physiological ratio(s) of the surface area to the volume of a tissue to be modeled.
In certain embodiments, the invention relates to any of the devices described herein, wherein the membrane can have any thickness provided that the selected thickness does not significantly affect the flexibility of the membrane or cell behavior and/or response. In accordance with some embodiments of the invention, the thickness of the membrane can range between 70 nanometers and 100 microns, or between 1 micron and 100 microns, or between 10 and 100 microns. In one embodiment, the thickness of the membrane can range between 10 microns and 50 microns. In some embodiments, the thickness of the membrane can range between 100 nm to about 10 microns. While the membrane generally has a uniform thickness across the entire length or width, in accordance with some embodiments of the invention, the membrane can be designed to include regions which have lesser or greater thicknesses than other regions in the membrane. The decreased thickness area(s) can run along the entire length or width of the membrane or can alternatively be located at only certain locations of the membrane. The decreased thickness area can be present along the bottom surface of the membrane, or additionally/alternatively be on the opposing surface of the membrane. It should also be noted that at least portions of the membrane can have one or more larger thickness areas relative to the rest of the membrane, and capable of having the same alternatives as the decreased thickness areas described above.
In certain embodiments, the invention relates to any of the devices described herein, wherein the second sheet comprises polycarbonate.
In certain embodiments, the invention relates to any of the devices described herein, wherein the second sheet comprises collagen.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device further comprises a clamp. In certain embodiments, the clamp ensures that the co-folded layers remain in place after the folding is complete and prevents leakage.
In certain embodiments, the invention relates to any of the devices described herein, wherein adjacent layers are covalently bonded to each other.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device further comprises an adhesive or other bonding interlayer oriented between co-folded layers of first sheet and second sheet.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device comprises an interlocked folded architecture.
In certain embodiments, the invention relates to any of the devices described herein, wherein selected regions of the first sheet are laser-cut, water-jet cut, punched out, hand cut, etched, molded in elastomers or other polymers, or in other ways removed from the first sheet.
In certain embodiments, the invention relates to any of the devices described herein, wherein the first sheet comprises a pattern defining preferential locations for folding. For example, laser-cutting may be used to pattern crease locations. The inclusion of pre-defined crease locations is optional but not required.
In certain embodiments, the invention relates to any of the devices described herein, wherein the device further comprises a sensor. For example, a sensor may be a small electronic chip that measures a quantity of interest (e.g. resistivity of the neighboring fluid). Such a sensor may be laminated onto an adhesive-coated sheet and folded into the stack. Alternatively, sensors may be incorporated by other means, such as by coating binding agents onto a sheet to identify the presence of certain species inside the device.
In certain embodiments, the invention relates to any of the devices or methods described herein, further comprising a first cell or a plurality of first cells (i.e., a first cell population) in the space defined by the first region or first fluid flow path. In certain embodiments, the invention relates to any of the devices or methods described herein, further comprising a second cell or a plurality of second cells (i.e., a second cell population) in the space defined by the second region or second fluid flow path. Cells may be seeded in the device using cell seeding techniques similar to those used in other microfluidic and tissue culture systems. For example, cells in a carrier liquid of cell culture medium may be flowed into the device and permitted to attach to device walls that are suitably coated and prepared for their attachment. Alternatively, the cells may be seeded first, and the stack may then be folded.
To seed cells into the device, a portion of the second sheet (or membrane) can be treated by coating at least one surface with one or more cell adhesion agents (e.g., extracellular matrix molecules comprising glycoproteins, collagen, fibronectin, laminin, vitronectin, elastins, fibrin, proteoglycans, heparin sulfate, chondroitin sulfate, keratan sulfate, hyaluronic acid, or any combinations thereof). In accordance with some embodiments of the invention, no treatment is needed. A first fluid containing a first desired cell population can flow into the first inlet, travel into the first central hole and exit through the first outlet. Optionally and independently, the second fluid containing a second desired cell population can flow into the second inlet, travel into the second central hole and exit through the second outlet. In an alternative embodiment, the inlets and outlets can be switched. In accordance with embodiments of the invention, a first cell population can be seeded on the top surface of the membrane, while optionally a second cell population can be seeded on the bottom surface of the membrane.
Once cells are seeded into the device, fluids containing the necessary nutrients (e.g., oxygen) and growth factors can flow through the central holes. In accordance with some embodiments of the invention, the membrane comprises a plurality of pores or apertures therethrough, whereby molecules, fluid or any media is capable of passing through the membrane via one or more pores in the membrane. Exogenous agents (e.g., drugs) can be introduced to the central holes to evaluate cellular responses.
Described herein are devices comprising co-folded stacks that mimic layered biological tissue. Each device may include multiple layers or multiple flow spaces and channels. It is also possible to combine multiple devices together into a single, multi-device architecture. In such an architecture, flow channels similar to the individual-unit flow channels defined here may be used to connect multiple individual devices together to a common set of inlets and outlets for scaled-up operation.
Devices and methods described in U.S. Patent Application Publication No. 2017/0327781 and U.S. Patent Application Publication No. 2015/0240194 are incorporated by reference.
Unless explicitly defined herein, all technical and scientific terms have the same meaning as commonly understood by one of ordinary skill in the arts to which this invention belongs. Where a term is provided in the singular, the inventor also contemplates the plural of that term.
“Microfluidic device,” as used herein, refers to a device, apparatus or system including at least one fluid-flow path having a dimension (e.g., height, length or depth) of less than 10 or 5 millimeters (mm). Generally the fluid-flow path will have a width of less than 1 mm.
“Fluid-flow path,” “fluid path” or “flow path” as used herein, refer to any channel, tube, region, space or pathway or portion thereof through which a fluid, including a liquid or a gas, may pass. A “fluid flow passageway” includes a portion of a fluid-flow path. Each fluid-flow path may be operably connected to a fluid inlet and a fluid outlet. Fluid inlets are holes, channels or other means for a fluid such as cell culture media to be conducted from outside the device into the fluid-flow path. Fluid outlets are also holes, channels or other means for a fluid such as conditioned or waste cell culture media to be conducted away from the device.
The fluid-flow paths can be varied in any dimension (e.g., length, width or depth) so as to produce a desired flow resistance. For example, the flow rate through a flow path can be regulated as a function of the hydrostatic pressure gradient across an inlet and an outlet. One or more fluid-flow paths may function as a resistance channel, meaning that the fluid-flow path has increased resistance to a fluid flow, either continuous or discontinuous (pulsatile) in nature. Resistance channels may contain, for example, tortuous curves or other geometric forms that increase fluid resistivity.
The invention, having been generally described, may be more readily understood by reference to the following examples, which are included merely for purposes of illustration of certain aspects and embodiments of the present invention, and are not intended to limit the invention in any way. All headings are for the convenience of the reader and should not be used to limit the meaning of the text that follows the heading, unless so specified.
The first sheet is double-sided polyimide tape that has been patterned to define flow channels (which are similar in function to liver sinusoids). The polyimide tape includes a double-sided acrylic adhesive that is also patterned. UV laser-cutting is a suitable technique for patterning this material.
The second sheet is a polycarbonate nanoporous membrane (which permits diffusion similar to the diffusion across the fenestrated endothelium and the Space of Disse in a native liver lobule). In this embodiment, the nanoporous membrane may be pre-patterned with through-holes that permit access to the flow channels, or the through holes may be defined after the system is folded for enhanced self-alignment.
In this example, the layers are oriented at 90 degrees from each other with alternating or irregularly alternating folds that are perpendicular to the layers' lengths. In this particular embodiment, the co-folding of the two layers produces a folded, engineered tissue architecture like the one shown schematically in
The inner structure and function of this folded tissue architecture are illustrated in
When combined with inlets and outlets that are patterned into the stack, this architecture defines an alternating set of spaces in which either hepatocytes or endothelial cells can be seeded. The spaces seeded with hepatocytes mimic the hepatocyte layers in native liver lobules. The spaces seeded with endothelial cells mimic the sinusoids in native liver lobules. These spaces are separated by nanoporous membrane layers so that the two cell types may communicate by diffusion. The patterning of the individual layers produces a set of inlet channels that separately access the “hepatocyte” and “sinusoid” spaces. As in native liver lobules, flow is delivered only to the endothelial cell-seeded spaces that mimic liver sinusoids. The only means by which nutrients are delivered to and products are removed from the hepatocyte spaces is diffusion through the nanoporous membranes, from the endothelial cell-lined spaces that mimic sinusoids.
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. While specific embodiments of the subject invention have been discussed, the above specification is illustrative and not restrictive. Many variations of the invention will become apparent to those skilled in the art upon review of this specification. The full scope of the invention should be determined by reference to the claims, along with their full scope of equivalents, and the specification, along with such variations. Such equivalents are intended to be encompassed by the following claims.
This application claims the benefit of priority to U.S. Patent Application Ser. No. 62/471,532, filed Mar. 15, 2017.
This invention was made with government support under Grant No. 1332249 from the National Science Foundation and the Air Force Office of Scientific Research. The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
62471532 | Mar 2017 | US |